Albert Marchio II

Mr. Marchio joins Brickell after successfully leading the financial teams of biomedical and life science companies for over 40 years. His extensive record of success includes an $82M IPO, almost $100M in crossover and Series A, B, and C financing, and invaluable experience within Investor Relations, Risk Management, SOX, Building Corporate Culture, Human Resource Management, Benefit Finance, IT Management, Tax Planning and Compliance.

Prior to joining Brickell, Mr. Marchio consulted for public (CytomX Therapeutics (CTMX)) and private life sciences companies. He served in various finance and accounting leadership roles from 2011 to 2018 at Edge Therapeutics, Inc. (now known as PDS Biotechnology Corporation), a clinical-stage biopharmaceutical company, including Chief Accounting and Administrative Officer, Interim Chief Financial Officer, Chief Accounting and Operations Officer and Chief Financial Officer.

Mr. Marchio was a Managing Operating Partner with Three Fields Capital, a multi-strategy healthcare focused investment firm and provided consulting services to life science companies through Rockabye Valley Consulting from January 2009 to May 2013. Previously, Mr. Marchio served as the Executive Vice President, Chief Financial Officer of Informed Medical Communications from February 2008 to October 2009, and as the Vice President, Treasurer of MedPointe Pharmaceuticals from 2006 to January 2008. He began his career in life sciences as the Vice President, Treasurer of Alpharma, Inc. from 1992 to 2005.